Mondelez leans on Oreo and Ritz growth, product innovation and wider distribution to strengthen biscuit sales despite a soft U.S. category.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Mondelez (MDLZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Mondelez's innovation pipeline spans Biscoff, Ritz, Toblerone and Sour Patch Kids as the snacking giant works to rebuild demand beyond pricing.
Mondelez International (MDLZ) is upgraded to Buy, reflecting resilience amid macro headwinds and a valuation offering margin of safety. MDLZ delivered solid Q1 results, maintaining strong market positions and projecting $3B FCF in 2026 despite the previously anticipated cocoa price and inventory pressures. Management expects 2026 to be a weaker year compared to their long-term algorithm, with 0–2% organic net revenue growth, followed by stronger performance as macro pressures ease.
Mondelez (MDLZ) reported earnings 30 days ago. What's next for the stock?
A golden cross, when the 50-day simple moving average climbs above the 200-day SMA, is one of the more closely watched technical signals on Wall Street.
MDLZ posts 3% organic revenue growth in Q1 as emerging markets lead and core snack categories hold up despite cost pressures.
I upgrade Mondelez (MDLZ) to a buy as profitability shows early signs of improvement and downside risk appears limited. Market sentiment is lagging behind as the overall impact on 2026 results is likely to be limited, but a medium to long-term opportunity exists. With pricing initiatives already in place, investors should also look for a potential stabilization of volumes through the rest of 2026.
MDLZ's chocolate organic net revenues rise 5.5% in Q1 2026 as pricing offsets volume dips. Europe's trends improve, and new launches sell out.
Examine the evolution of Mondelez's (MDLZ) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
At 32x earnings, some investors would push back on the idea that MDLZ is a value stock. But forward earnings of about 20x hints that it could be a value play.